American volunteers began rolling up their sleeves and receiving injections yesterday in the first-ever large-scale human test of an AIDS vaccine. The three-year trial of Vaxgen Inc.'s AIDS-VAX is intended to learn whether it can protect people from infection with the AIDS virus. The testing is the final step before the U.S. Federal Drug Administrations approval.